Pharmaceuticals Insider Trading
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
Activity
About industry performance (blue line)
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.
Recent Transactions
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2015 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 27,875 | $14.20 | $395,825.00 | -0.6% | |
| Jun 11, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $32.38 | $388,547.20 | -6.5% | |
| Jun 11, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $32.38 | $388,547.20 | -6.5% | |
| Jun 10, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $82.39 | $17,302,518.87 | - | |
| Jun 10, 2015 | PBH Prestige Consumer Healthcare Inc. | Parkinson John | Senior Vp- International | Sell | 9,104 | $44.29 | $403,216.16 | -10.3% | |
| Jun 9, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Zhang Jack Y.45 | CEO &Chief Science Officer | Sell | 193,758 | $16.43 | $3,183,419.43 | -3.9% | |
| Jun 8, 2015 | JNJ Johnson & Johnson | Johnson & Johnson59 | 10% Owner | Sell | 1,010,265 | $47.94 | $48,432,104.10 | -32.8% | |
| Jun 8, 2015 | TXMD Therapeuticsmd, Inc. | Krassan Mitchell | EVP, Chief Strategy Officer | Sell | 30,000 | $8.18 | $245,400.00 | -100% | |
| Jun 5, 2015 | SIGA Siga Technologies Inc | Hruby Dennis E | VP &Chief Scientific Officer | Sell | 40,000 | $1.62 | $64,765.00 | -10.1% | |
| Jun 4, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $77.90 | $15,579,998.60 | - | |
| Jun 4, 2015 | SIGA Siga Technologies Inc | Rose Eric A Md | Chief Executive Officer | Sell | 25,000 | $1.67 | $41,641.00 | -1.8% | |
| Jun 4, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $33.68 | $404,181.20 | -8.0% | |
| Jun 4, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $33.68 | $404,181.20 | -8.0% | |
| Jun 2, 2015 | JNJ Johnson & Johnson | Prince Charles | Director | Buy | 2,500 | $99.22 | $248,050.00 | +12.1% | |
| Jun 1, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 220,000 | $79.36 | $17,460,080.00 | -0.2% | |
| Jun 1, 2015 | EBS Emergent Biosolutions Inc. | Havey Adam | EVP, Biodefense Divison | Buy | 98 | $27.08 | $2,653.84 | +0.2% | |
| Jun 1, 2015 | PBH Prestige Consumer Healthcare Inc. | Mannelly Matthew | President And CEO | Sell | 19,670 | $44.16 | $868,713.60 | -26.2% | |
| May 29, 2015 | LLY Eli Lilly & Co | Zakrowski Donald A | Chief Accounting Officer | Sell | 200 | $78.33 | $15,666.00 | -4.9% | |
| May 29, 2015 | LLY Eli Lilly & Co | Simmons Jeffrey N52 | SVP&Pres. Elanco Animal Health | Sell | 20,000 | $78.08 | $1,561,600.00 | -17.6% | |
| May 28, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 18,000 | $35.11 | $631,908.45 | -14.1% | |
| May 28, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 18,000 | $35.11 | $631,908.45 | -14.1% | |
| May 27, 2015 | SBFM Sunshine Biopharma Inc. | Slilaty Steve N. | Chief Executive Officer | Buy | 500,000 | $0.10 | $50,000.00 | New | |
| May 27, 2015 | ANIK Anika Therapeutics, Inc. | Moran John C | Director | Sell | 2,500 | $33.00 | $82,500.00 | -13.0% | |
| May 26, 2015 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 500 | $30.54 | $15,272.15 | -2.9% | |
| May 26, 2015 | CPIX Cumberland Pharmaceuticals Inc | Lawrence Thomas R | Director | Sell | 6,000 | $6.88 | $41,280.00 | -9.9% |